Michael Sasha John is a prominent inventor based in Larchmont, NJ (US), known for his significant contributions to the field of neurostimulation. With a total of four patents to his name, he has made remarkable advancements in medical technology aimed at improving patient care.

Latest Patents

One of his latest patents is a neurostimulation system with linked programming adjustment. This innovative system features an implanted neurostimulator equipped with a processor that controls stimulation parameter values. It creates stimulation signals applied to a patient's body, maintaining relative proportional amplitudes of a set of linked stimulation signals during stimulation according to a specific protocol. An external programmer receives user input data, allowing for adjustments to the stimulation protocol. The system includes independently operable electrode contacts that are electrically coupled to the neurostimulator, with at least two subsets of electrode contacts linked to receive the stimulation signals. Additionally, an information transmission system with telemetry circuitry transmits the stimulation signal values in accordance with the protocol.

Another notable patent involves neurostimulation treatment for abnormal connectivity with a cingulate region. This method guides targeted neurostimulation to a patient's brain by sensing neuroimaging data. A processor evaluates this data to calculate results for a modeled functional measure of a specific brain network, defining a first and second brain region. A target location is determined in the first brain region based on the result data and a functional connection measure between the two regions. A transcranial magnetic stimulator is then adjusted to provide a magnetic stimulation signal for the target location.

Career Highlights

Michael Sasha John is currently associated with Avertix Medical, Inc., where he continues to develop innovative solutions in neurostimulation technology. His work has significantly impacted the medical field, particularly in treating neurological conditions.

Collaborations

Throughout his career, Michael has collaborated with notable professionals, including David R. Fischell and David Keenan. These collaborations have further enhanced the development of his innovative technologies.

Conclusion

Michael Sasha John is a key figure in the advancement of neurostimulation technology, with multiple patents that reflect his dedication to improving patient outcomes. His work at Avertix Medical, Inc. and collaborations with esteemed colleagues underscore his commitment to innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com